[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366267-105":59,"doc-detail-366267-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","validation-of-data-quality-in-the-swedish-quality-register-of-gynecologic-cancer-for-cervical-cancer-and-vulvar-cancera-swedish-gynecologic-cancer-group-swe-gcg-study","Validation of data quality in the Swedish quality register of gynecologic cancer for cervical cancer and vulvar cancer—a Swedish gynecologic cancer group (Swe-GCG) study","","Population-based registers provide essential real-world data for cancer research and quality assurance, but their reliability depends on validated data quality. This study evaluated the Swedish Quality Register of Gynecologic Cancer (SQRGC) for cervical cancer and vulvar cancer by measuring completeness, timeliness, comparability, and validity. Completeness was assessed against the Swedish National Cancer Register, timeliness as time from diagnosis to registry entry, and comparability by adherence to international coding standards. Validity was tested by agreement between re-abstracted and original SQRGC data for 276 women.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/validation-of-data-quality-in-the-swedish-quality-register-of-gynecologic-cancer-for-cervical-cancer-and-vulvar-cancera-swedish-gynecologic-cancer-group-swe-gcg-study/366267/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/validation-of-data-quality-in-the-swedish-quality-register-of-gynecologic-cancer-for-cervical-cancer-and-vulvar-cancera-swedish-gynecologic-cancer-group-swe-gcg-study/366267.png","ImageObject",300,407,{"name":92,"@type":93},"Cart","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-19","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",16,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the main objective of the Swe-GCG study?","Question",{"text":113,"@type":114},"To evaluate the quality of data on cervical cancer and vulvar cancer in the SQRGC and ensure results from research and quality assurance use are robust and reliable.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was data quality assessed in the SQRGC?",{"text":118,"@type":114},"By evaluating completeness, timeliness, comparability, and validity, following guidance from IARC and Swedish validation recommendations for cancer registers.",{"name":120,"@type":111,"acceptedAnswer":121},"What did the study conclude about SQRGC data quality?",{"text":122,"@type":114},"The data for cervical and vulvar cancer in the SQRGC were of adequate quality and suitable for research and clinical purposes.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},366267,1790497631,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},18829141979164,"https://eur-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","DOI: 10. 1111/aogs.15152  \nOR I G I NAL R E S E AR C H  \nValidation of data quality in the Swedish quality register of gynecologic cancer for cervical cancer and vulvar cancer—a Swedish gynecologic cancer group (Swe-GCG) study  \nMaria Bjurberg1  | Kristina Hellman2 | Tim A. Säll3 | Christian Staf3 | Christer Borgfeldt4 | Erik Holmberg3 | Jenny Jönsson5 | Gabriel Lindahl6 | Angelique Flöter Rådestad7  | Camilla Sköld8 | Katja Stenström Bohlin9  | Karin Stålberg10  | Elisabeth Åvall-Lundqvist6 | Preben Kjølhede4  | Pernilla Dahm-Kähler3,9   \n1Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, and Lund University, Lund, Sweden  \n2Department of Gynecologic Cancer, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden 3 Regional Cancer Center Western Sweden, Gothenburg, Sweden 4Department of Obstetrics and Gynecology, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden 5Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden  \n6Department of Oncology, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden  \n7Department of Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska Institute, Stockholm, Sweden  \n8 Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden  \n9Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden 10 Department of Women's and Children's Health, Uppsala University, Uppsala,  \nAbstract  \nIntroduction: Population-based registers provide an important source of real-world data. The growing number of large cohort studies using data from cancer registers makes validation of such registers important. The Swedish Quality Register of Gynecologic Cancer (SQRGC) is a nationwide population-based register containing data on patient and tumor characteristics, treatment, and follow-up. To ensure that the results from research and quality assurance reports using SQRGC data are robust and reliable, the accuracy and completeness of the register need to be validated. The aim of this study was to evaluate the quality of data on cervical cancer and vulvar cancer in the SQRGC.  \nMaterial and Methods: Quality of data in the SQRGC was investigated by evaluating completeness, timeliness, comparability, and validity in accordance with recommendations from the International Agency for Research on Cancer and the national Swedish guidelines on validation of cancer registers. Completeness was evaluated by coverage relative to the Swedish National Cancer Register, and timeliness as the time from diagnosis until entry into the SQRGC. We randomly selected 276 women diagnosed with cervical cancer (n = 138) and vulvar cancer (n = 138) between 2014 and 2019 for validation. An external monitor manually re-abstracted data on 10 core variables per sub-register from the patients' medical records. Comparability was assessed by reviewing the adherence to international standards regarding coding. Validity was evaluated by the agreement between re-abstracted data and original data in the SQRGC. Correlations were estimated using Pearson's correlation coefficient and Cohen's kappa coefficient.  \n\n| Abbreviations: IARC, International Agency for Research on Cancer; NCR, The Swedish National Cancer Register; SQRGC, The Swedish Quality Register of Gynecologic Cancer. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.\u003Cbr>© 2025 The Author(s) . Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG) . |\n\n[1530](1530 | wileyonlinelibra","cbCairO7vqXe5wr5","https://ap.wps.com/l/cbCairO7vqXe5wr5","pdf",898466,"English","# Abstract\n## Introduction\n## Material and Methods\n## Results\n## Conclusions\n# Keywords\n# Introduction","[{\"question\":\"What was the main objective of the Swe-GCG study?\",\"answer\":\"To evaluate the quality of data on cervical cancer and vulvar cancer in the SQRGC and ensure results from research and quality assurance use are robust and reliable.\"},{\"question\":\"How was data quality assessed in the SQRGC?\",\"answer\":\"By evaluating completeness, timeliness, comparability, and validity, following guidance from IARC and Swedish validation recommendations for cancer registers.\"},{\"question\":\"What did the study conclude about SQRGC data quality?\",\"answer\":\"The data for cervical and vulvar cancer in the SQRGC were of adequate quality and suitable for research and clinical purposes.\"}]","Validation of data quality in the Swedish quality register of gynecologic cancer for cervical cancer and vulvar cancer—a Swedish gynecologic cancer group (Swe-GCG) study | PDF",1790164487,23,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2414723103af4c5deea419e14442c227.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b5ddf8838b179f3ac662170fc1a08db8.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/69f04423d66f2cf126595f03ba6cab2d.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ada3785e1743d323ef14ced18b8248a0.webp",980,1287]